| Lactose (India) Ltd | 120 Cr. | 95.4 | 137/84.3 | 24.9 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.21 Cr. | 1.68 | 4.02/1.68 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 3,612 Cr. | 335 | 479/208 | 75.6 | 24.3 | 0.20 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 30.4 Cr. | 41.0 | 79.8/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 90.8 Cr. | 62.0 | 62.2/17.0 | 363 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 62.1 Cr. | 82.5 | 115/69.7 | 17.8 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 57,685 Cr. | 2,043 | 2,286/1,275 | 21.3 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 284 Cr. | 11.7 | 17.2/10.8 | 16.2 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.09 Cr. | 12.0 | 14.8/9.25 | 88.6 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 893 Cr. | 1,664 | 1,999/635 | 26.2 | 294 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 99.0 Cr. | 19.8 | 29.8/17.0 | 28.7 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 942 Cr. | 320 | 399/219 | 10.6 | 133 | 0.78 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 2.75 Cr. | 13.1 | 39.0/13.0 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 8.01 Cr. | 3.22 | 8.28/2.11 | 4.55 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 358 Cr. | 369 | 536/211 | 61.4 | 0.00 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,673 Cr. | 1,079 | 1,511/944 | 40.2 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 45.0 Cr. | 0.22 | 1.12/0.20 | 2.96 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 24.8 Cr. | 9.45 | 26.3/9.19 | 12.1 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 8.57 Cr. | 8.49 | 13.0/7.50 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 156 Cr. | 438 | 805/415 | 10.9 | 596 | 0.34 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 84.4 Cr. | 84.4 | 92.5/26.1 | 159 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 11,486 Cr. | 1,098 | 2,150/1,090 | 36.2 | 174 | 0.97 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 6.30 Cr. | 50.0 | 88.7/36.1 | 12.8 | 39.2 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 12.5 Cr. | 5.01 | 7.66/2.99 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 14.8 Cr. | 99.0 | 153/79.5 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 46.5 Cr. | 85.0 | 144/12.2 | 22.6 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 30.3 Cr. | 40.1 | 69.0/33.0 | 48.8 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 5.63 Cr. | 18.7 | 24.4/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 6,171 Cr. | 356 | 1,028/353 | 21.0 | 72.4 | 0.34 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 78.7 Cr. | 18.2 | 28.8/16.6 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.0 Cr. | 21.7 | 30.0/17.4 | 1,100 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 83,580 Cr. | 2,024 | 2,727/2,015 | 47.3 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 249 Cr. | 432 | 524/241 | 23.9 | 123 | 1.04 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 68.1 Cr. | 47.5 | 51.5/26.7 | 92.1 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 67,597 Cr. | 1,164 | 1,279/994 | 19.2 | 603 | 0.35 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 181 Cr. | 291 | 317/159 | 61.5 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 752 Cr. | 75.1 | 115/68.0 | 18.0 | 32.6 | 2.00 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 31.7 Cr. | 24.3 | 39.7/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 17,260 Cr. | 2,108 | 2,170/930 | 60.2 | 173 | 0.07 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.89 Cr. | 0.74 | 1.06/0.51 | 69.8 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 202 Cr. | 26.4 | 44.6/23.1 | 11.4 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 8.63 Cr. | 14.8 | 19.1/7.60 | 288 | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 128 Cr. | 5.43 | 6.80/2.82 | 297 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 55,908 Cr. | 26,316 | 37,000/26,006 | 36.7 | 1,888 | 1.81 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,332 Cr. | 698 | 972/557 | 29.3 | 226 | 0.72 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 226 Cr. | 78.8 | 100/31.3 | 65.8 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,465 Cr. | 1,322 | 1,740/752 | | 93.5 | 0.08 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 22,440 Cr. | 1,380 | 1,870/1,110 | 206 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 939 Cr. | 270 | 330/154 | 21.8 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 67.1 Cr. | 8.08 | 29.4/6.65 | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 1,030 Cr. | 774 | 873/278 | 13.5 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 2,590 Cr. | 369 | 728/361 | 24.6 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,314 Cr. | 929 | 1,402/923 | 18.9 | 768 | 1.08 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,43,460 Cr. | 4,238 | 4,336/2,886 | 62.2 | 250 | 0.75 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 818 Cr. | 88.9 | 183/75.2 | | 41.3 | 0.56 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,235 Cr. | 13.2 | 23.5/11.5 | 17.9 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 11,695 Cr. | 306 | 1,265/303 | 38.9 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,506 Cr. | 151 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,13,849 Cr. | 1,725 | 1,851/1,547 | 34.1 | 324 | 0.93 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,086 Cr. | 470 | 734/440 | | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 3,491 Cr. | 373 | 388/175 | 40.0 | 81.2 | 0.11 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,335 Cr. | 324 | 502/260 | 35.8 | 125 | 0.15 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,275 Cr. | 4,025 | 6,718/3,966 | 25.1 | 340 | 2.91 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,125 Cr. | 1,901 | 2,725/1,772 | 29.8 | 335 | 1.05 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 8,396 Cr. | 5,055 | 6,739/4,904 | 28.6 | 373 | 2.47 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 124 Cr. | 35.0 | 76.0/30.6 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 22,562 Cr. | 4,932 | 5,993/3,701 | 29.6 | 841 | 0.71 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 121 Cr. | 98.1 | 134/81.0 | 8.66 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,083 Cr. | 340 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 3,372 Cr. | 669 | 1,065/604 | 130 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 16,251 Cr. | 12,654 | 19,748/10,060 | 90.7 | 1,263 | 0.09 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 246 Cr. | 12.7 | 30.7/12.5 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 15,957 Cr. | 891 | 1,060/660 | 10.3 | 483 | 0.68 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,153 Cr. | 39.3 | 70.5/33.5 | 28.2 | 21.8 | 0.51 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,053 Cr. | 178 | 271/156 | 22.4 | 59.3 | 0.45 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 50.9 Cr. | 32.1 | 108/22.7 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 225 Cr. | 62.8 | 129/61.9 | | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 1,01,470 Cr. | 2,220 | 2,263/1,774 | 20.4 | 430 | 0.54 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,237 Cr. | 618 | 679/440 | 14.1 | 357 | 0.29 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 54,985 Cr. | 1,019 | 1,141/512 | 68.7 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 1,498 Cr. | 1,444 | 1,599/596 | 26.2 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 129 Cr. | 60.0 | 114/51.0 | | 74.6 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 628 Cr. | 130 | 215/120 | 38.0 | 104 | 2.30 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 549 Cr. | 315 | 500/265 | 21.1 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 13,944 Cr. | 876 | 1,250/802 | 30.2 | 414 | 0.58 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 32,076 Cr. | 1,997 | 2,015/1,303 | 42.6 | 243 | 0.78 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,150 Cr. | 172 | 302/155 | 27.0 | 37.9 | 1.46 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 36,974 Cr. | 1,457 | 1,595/1,168 | 35.0 | 293 | 0.27 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,151 Cr. | 73.3 | 127/57.5 | 17.3 | 59.7 | 1.35 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 19.9/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 1,153 Cr. | 141 | 150/67.2 | 24.4 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 1,828 Cr. | 199 | 350/190 | | 106 | 0.10 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,499 Cr. | 202 | 457/177 | 99.9 | 96.9 | 0.69 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,333 Cr. | 1,560 | 2,350/1,243 | 32.6 | 397 | 0.45 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 2,906 Cr. | 288 | 410/284 | 57.5 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 14,493 Cr. | 597 | 627/412 | 26.7 | 164 | 0.27 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 57,685 Cr. | 2,043 | 2,286/1,275 | 21.3 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 44,039 Cr. | 2,600 | 3,516/2,220 | 43.8 | 101 | 1.64 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 30,059 Cr. | 1,822 | 2,131/1,200 | 25.4 | 610 | 0.98 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 5,992 Cr. | 368 | 528/357 | 25.8 | 149 | 1.35 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 18,718 Cr. | 1,350 | 1,910/1,097 | 42.1 | 227 | 0.55 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,06,822 Cr. | 1,280 | 1,380/1,020 | 19.1 | 432 | 0.62 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 2,855 Cr. | 182 | 322/178 | 21.6 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,08,388 Cr. | 1,341 | 1,673/1,282 | 22.8 | 408 | 0.98 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 12,891 Cr. | 1,696 | 2,397/1,551 | 21.0 | 416 | 0.35 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 219 Cr. | 74.4 | 166/58.4 | 10.1 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 2,359 Cr. | 223 | 244/105 | 21.3 | 107 | 0.22 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 56.5 Cr. | 35.0 | 57.2/28.5 | 20.4 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 62,186 Cr. | 384 | 425/291 | 75.7 | 200 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,072 Cr. | 1,062 | 2,000/1,048 | 24.9 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 125 Cr. | 78.5 | 129/64.0 | 15.4 | 49.2 | 1.52 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 275 Cr. | 116 | 205/69.9 | 24.0 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 22,257 Cr. | 8,906 | 10,691/6,502 | 107 | 320 | 0.36 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,783 Cr. | 615 | 791/544 | 30.8 | 118 | 0.75 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 143 Cr. | 67.2 | 125/61.0 | 12.1 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 64,445 Cr. | 5,390 | 5,934/4,492 | 26.8 | 1,116 | 0.84 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 14,970 Cr. | 762 | 1,108/725 | 22.6 | 271 | 1.45 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 407 Cr. | 731 | 959/663 | 42.4 | 690 | 0.67 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 36,640 Cr. | 2,932 | 3,021/2,022 | 36.1 | 345 | 0.96 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,522 Cr. | 315 | 367/258 | 24.5 | 133 | 1.68 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,392 Cr. | 372 | 575/312 | 18.3 | 147 | 0.54 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 20,119.61 Cr | 1,088.74 | | 57.00 | 201.33 | 0.37% | 16.29% | 15.20% | 6.10 |